Eiken Chemical Co (TSE:4549) EBIT: 円4,863 Mil (TTM As of Mar. 2026)


TSE:4549 Eiken Chemical Co Ltd TSE:4549
81 GF Score
Price 円2,525.00
GF Value 円2,477.93
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Eiken Chemical Co EBIT?

Eiken Chemical Co TSE:4549 +1.45% 81 EBIT is 円4,863 Mil as of Mar. 2026. GuruFocus rates TSE:4549 with a GF Score™ of 81/100 and a GF Value™ of 円2,477.93 (Fairly Valued). The stock has 4 warning signs investors should review.

Eiken Chemical Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was 円118 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円4,863 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Eiken Chemical Co's annualized ROC % for the quarter that ended in Mar. 2026 was 0.00%. Eiken Chemical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1.38%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Eiken Chemical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 6.14%.


Eiken Chemical Co  (TSE:4549) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Eiken Chemical Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=560 * ( 1 - 100% )/( (48505 + 45814)/ 2 )
=0/47159.5
=0.00 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Eiken Chemical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=472/( ( (23575 + max(11438, 0)) + (23338 + max(9818, 0)) )/ 2 )
=472/( ( 35013 + 33156 )/ 2 )
=472/34084.5
=1.38 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(12656 + 8816 + 2077) - (5784 + 0 + 6327)
=11438

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(10168 + 7991 + 2584) - (5546 + 0 + 5379)
=9818

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Eiken Chemical Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=4863/79232.072
=6.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eiken Chemical Co EBIT Related Terms


Eiken Chemical Co EBIT Historical Data

* Premium members only.

The historical data trend for Eiken Chemical Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eiken Chemical Co EBIT Chart

Eiken Chemical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,489.00 7,608.00 3,520.00 3,008.00 4,863.00

Eiken Chemical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 118.00 818.00 2,920.00 1,007.00 118.00

TSE:4549 vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Eiken Chemical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eiken Chemical Co EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eiken Chemical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Eiken Chemical Co's EV-to-EBIT falls into.


TSE:4549
81GF Score
Eiken Chemical Co Ltd TSE:4549
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eiken Chemical Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円4,863 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円4,863 Mil mean?
Eiken Chemical Co (TSE:4549) has a EBIT of 円4,863 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Eiken Chemical Co.
Is Eiken Chemical Co's EBIT too high?
Eiken Chemical Co's current EBIT is 円4,863 Mil. Overall, Eiken Chemical Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eiken Chemical Co's EBIT compare to ABT and SYK?
Eiken Chemical Co's EBIT of 円4,863 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Eiken Chemical Co. Eiken Chemical Co's current EBIT is 円4,863 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiken Chemical Co stock overvalued right now?
Based on GuruFocus' analysis, Eiken Chemical Co (TSE:4549) is currently considered Fairly Valued. The stock's GF Value™ is 円2,477.93, compared to a current price of 円2,525.00 — trading 1.9% above its estimated fair value. The current EBIT is 円4,863 Mil. Eiken Chemical Co's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Eiken Chemical Co (TSE:4549), the current EBIT is 円4,863 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eiken Chemical Co (TSE:4549) Overvalued in 2026?

Based on GuruFocus' analysis, Eiken Chemical Co stock appears to be overvalued. The current stock price of 円2,525.00 is trading 1.9% above its estimated GF Value™ of 円2,477.93. GuruFocus considers Eiken Chemical Co to be Fairly Valued.

Key valuation signals for TSE:4549:

  • EBIT: 円4,863 Mil
  • GF Value™: 円2,477.93 vs. price of 円2,525.00 (1.9% above fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the TSE:4549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eiken Chemical Co Business Description

Address 4-19-9 Taito, Taito-ku, Tokyo, JPN, 110-8408
Eiken Chemical Co Ltd is a Japan-based company. It manufactures and sells clinical diagnostics and equipment. The company is engaged in processing, manufacture, purchase and sale of test agents, property and casualty insurance agency business. It as a general manufacturer of clinical diagnostics offers a wide range of in vitro diagnostic aids for all fields of medicine. Its major products include the Fecal immunochemical test, Molecular Genetics (LAMP), Microbiology, among many others.
81GF Score

Get the complete analysis for TSE:4549

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,525.00
Price
円2,477.93
GF Value